SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-16-121888
Filing Date
2016-05-18
Accepted
2016-05-18 16:55:17
Documents
1
Group Members
VERSANT CAPITAL IV (SWITZERLAND) GMBHVERSANT IV LUXCO S.A R.L.VERSANT VENTURE CAPITAL IV, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D a16-11401_1sc13d.htm SC 13D 203528
  Complete submission text file 0001104659-16-121888.txt   205286
Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 650-233-2211
Versant Ventures IV, LLC (Filed by) CIK: 0001456589 (see all company filings)

IRS No.: 263080143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88266 | Film No.: 161661047
SIC: 2836 Biological Products, (No Diagnostic Substances)